Researching a New Drug for Anxiety First Steps In order to prepare for to research a new drug treatment with human beings, a number of things have to be taken into consideration. The first is the type of anxiety which is under consideration. As Nevid and Rathus (2005) write, anxiety disorders are Axis 1 Clinical Syndromes which impair functioning and are stressful to the individual. They include a wide range of diagnostic classes, but in general, anxiety is an emotional state that is accompanied by subjective, behavioral, and physical features. The challenge involved in diagnosis and treatment is that anxiety is an appropriate response to a real threat. It can be seen as abnormal, however, when it is excessive or when it comes out of...The end:
.....ozak, M., Davies, S., Campeas, R., Franklin, M., Huppert, J., Kjernisted, K., Rowan, V., Schmidt, A., Simpson, H., & Tu, X. (2005). Randomized, Placebo-Controlled Trial of Exposure and Ritual Prevention, Clomipramine, and Their Combination in the Treatment of Obsessive-Compulsive Disorder. Am J Psychiatry, 162, 151–161. Mataix-Cole, D., Rauch, S., Manzo, P., Jenike, M., & Baer, L. (1999). Use of Factor-Analyzed Symptom Dimensions to Predict Outcome With Serotonin Reuptake Inhibitors and Placebo in the Treatment of Obsessive-Compulsive Disorder. Am J Psychiatry, 156, 1409-1416. Nevid, J.S., & Rathus, S.A. (2005). Psychology and the challenges of life: Adjustment in the new millennium (9th ed.). Hoboken, NJ: John Wiley & Sons.